A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Study Identifier
191622-140
CT.gov Identifier
NCT02590250
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Bladder Disorder - Overactive Bladder
    • Study Drug
  • botulinum toxin Type A
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patients with urinary incontinence due to NDO or OAB treated with BOTOX® as per local standard of care in clinical practice.
    Exclusion Criteria:
    * None

    Protocol Summary

    This is a Post-Marketing Surveillance study in India to evaluate safety and efficacy of BOTOX® (Botulinum Toxin Type A) in the treatment of patients with urinary incontinence due to neurogenic detrusor overactivity or overactive bladder.

    Study Locations

    Location
    Status
    Location
    NU Hospitals
    Padmanabha Nagar, Banglore, India, 560070
    Status
    Not applicable
    Location
    Bodyline Hospitals
    Ahmedabad, Gujarat, India, 380007
    Status
    Not applicable
    Location
    Fortis Hospitals
    Bengaluru, Karnataka, India, 560076
    Status
    Not applicable
    Location
    Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute
    Mumbai, Maharashtra, India, 400053
    Status
    Not applicable
    Location
    AMAI Charitable Trust's ACE Hospital and Research Centre
    Pune, Maharashtra, India, 411004
    Status
    Not applicable
    Location
    Inamdar Multispeciality Hospital
    Pune, Maharashtra, India, 411040
    Status
    Not applicable
    Showing {first} - {last} of {total} Results